This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2019 Mar 26;321(12):1219.

doi: 10.1001/jama.2018.22119.

Adverse Events Associated With Immune Checkpoint Inhibitors

Halis Kaan Akturk¹, Aaron W Michels¹

Affiliations

PMID: 30912828
DOI: 10.1001/jama.2018.22119

Comment

Adverse Events Associated With Immune Checkpoint Inhibitors

Halis Kaan Akturk et al. JAMA. 2019.

. 2019 Mar 26;321(12):1219.

doi: 10.1001/jama.2018.22119.

Authors

Halis Kaan Akturk¹, Aaron W Michels¹

Affiliation

¹ Barbara Davis Center for Diabetes, University of Colorado, Aurora.

PMID: 30912828
DOI: 10.1001/jama.2018.22119

No abstract available

PubMed Disclaimer

Comment in

Adverse Events Associated With Immune Checkpoint Inhibitors-Reply.
Johnson DB, Chandra S, Sosman JA. Johnson DB, et al. JAMA. 2019 Mar 26;321(12):1219-1220. doi: 10.1001/jama.2018.22123. JAMA. 2019. PMID: 30912830 No abstract available.

Comment on

Immune Checkpoint Inhibitor Toxicity in 2018.
Johnson DB, Chandra S, Sosman JA. Johnson DB, et al. JAMA. 2018 Oct 23;320(16):1702-1703. doi: 10.1001/jama.2018.13995. JAMA. 2018. PMID: 30286224 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions

Substances

Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems